0001209191-22-043143.txt : 20220725
0001209191-22-043143.hdr.sgml : 20220725
20220725181808
ACCESSION NUMBER: 0001209191-22-043143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220721
FILED AS OF DATE: 20220725
DATE AS OF CHANGE: 20220725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolchko J Scott
CENTRAL INDEX KEY: 0001586893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 221104533
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-21
0
0001434316
FATE THERAPEUTICS INC
FATE
0001586893
Wolchko J Scott
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
1
1
0
0
President and CEO
Common Stock
2022-07-21
4
M
0
30000
2.70
A
461546
D
Common Stock
2022-07-21
4
S
0
10829
32.54
D
450717
D
Common Stock
2022-07-21
4
S
0
19171
33.07
D
431546
D
Common Stock
2022-07-22
4
M
0
6246
2.70
A
437792
D
Common Stock
2022-07-22
4
S
0
2923
31.33
D
434869
D
Common Stock
2022-07-22
4
S
0
2703
32.61
D
432166
D
Common Stock
2022-07-22
4
S
0
620
33.28
D
431546
D
Stock Option (Right to Buy)
2.70
2022-07-21
4
M
0
30000
0.00
D
2027-01-03
Common Stock
30000
6246
D
Stock Option (Right to Buy)
2.70
2022-07-22
4
M
0
6246
0.00
D
2027-01-03
Common Stock
6246
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share.
Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share.
Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share.
Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share.
This option is fully vested.
/s/ Cindy Tahl, as Attorney-in-Fact
2022-07-25